Fundraising FoxInnovus Pharmaceuticals
San Diego, US · Nevada corporation
Find your way into Innovus Pharmaceuticals
Sign up to see every warm intro you have to Innovus Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Innovus Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BD
Bassam DamajPresident, Secretary and TreasurerDr. Bassam Damaj is a biotechnology entrepreneur who has founded and led multiple life-science ventures across North America, Europe, and the MENA region, with experience spanning oncology, infectious and autoimmune diseases, medical devices, and consumer health. He holds a Ph.D. and has published over 120 peer-reviewed papers and patents.
VL
Vivian LiuExecutive
WB
Wallace BoyackAll are prior status, not present status.
Board
HE
Henry EsberBoard director
ZM
Ziad MirzaBoard director
Reported raises · per SEC filings
Form D private placements$8.3M disclosed across 8 of 10 rounds · 2012–2019
▶$3.2MraisedJan 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$3.2MraisedJan 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bassam DamajExecutive Officer, Director
- Ziad MirzaDirector
- Vivian LiuDirector
- Ryan SelhornExecutive Officer
- Randy BerholtzExecutive Officer
- Dean NuhailyDirector
- Henry EsberDirector
- Offering amount
- $3.2M
- Amount sold
- $3.2M
- Sales commissions
- $354.6K
- Placement agents
- H.C. WAINWRIGHT and CO., LLC
- First sale
- Jan 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$145.2KraisedAug 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$145.2KraisedAug 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bassam DamajExecutive Officer, Director
- Offering amount
- $145.2K
- Amount sold
- $145.2K
- First sale
- Jul 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$3MraisedAug 2016 · 9 investors · PharmaceuticalsRule 506(b)
▶$3MraisedAug 2016 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bassam DamajExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $250K
- First sale
- Jun 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$500KraisedAug 2015 · PharmaceuticalsRule 506(b)
▶$500KraisedAug 2015 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ziad MirzaDirector
- Henry EsberDirector
- Bassam DamajExecutive Officer, Director
- Vivian LiuDirector
- Offering amount
- $1.5M
- Amount sold
- $500K
- First sale
- Aug 2015
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$16KraisedAug 2015 · PharmaceuticalsRule 506(b)
▶$16KraisedAug 2015 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Vivian LiuDirector
- Ziad MirzaDirector
- Henry EsberDirector
- Bassam DamajExecutive Officer, Director
- Offering amount
- $16K
- Amount sold
- $16K
- First sale
- Aug 2015
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$742.3KraisedFeb 2014 · 6 investors · PharmaceuticalsRule 506(b)
▶$742.3KraisedFeb 2014 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bassam DamajExecutive Officer, Director
- Henry EsberDirector
- Vivian LiuDirector
- Offering amount
- $742.3K
- Amount sold
- $742.3K
- First sale
- Feb 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$330KraisedFeb 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$330KraisedFeb 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bassam DamajExecutive Officer, Director
- Vivian LiuDirector
- Ziad MirzaDirector
- Henry EsberDirector
- Offering amount
- $330K
- Amount sold
- $330K
- Minimum investment
- $300K
- First sale
- Feb 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$350KraisedJan 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$350KraisedJan 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bassam DamajExecutive Officer, Director
- Henry EsberDirector
- Ziad MirzaDirector
- Vivian LiuDirector
- Offering amount
- $350K
- Amount sold
- $350K
- Minimum investment
- $350K
- First sale
- Dec 2013
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Innovus Pharmaceuticals?
- Innovus Pharmaceuticals was founded by Bassam Damaj.
- How much funding has Innovus Pharmaceuticals raised?
- Innovus Pharmaceuticals has disclosed $8.3M raised across 8 of its 10 known rounds.
- Where is Innovus Pharmaceuticals headquartered?
- Innovus Pharmaceuticals is headquartered in San Diego, US.